News Year None2021202020192018 June 11, 2021 Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease June 10, 2021 Equillium Presents Data on Target Engagement and Modulation of CD6 on T Cells with Itolizumab at the International Society for Advancement of Cytometry June 9, 2021 Equillium to Present at the JMP Securities Life Sciences Conference June 7, 2021 Equillium to Collaborate with Oxford University and Kennedy Institute of Rheumatology to Investigate Role of the CD6-ALCAM Pathway and Itolizumab in Rheumatic Diseases June 3, 2021 Equillium to Host Conference Call Following Presentation of Data from the EQUATE Study in Acute Graft Versus Host Disease at the EHA2021 Virtual Congress of the European Hematology Association on June 11 May 26, 2021 Equillium to Present at the Jefferies Virtual Healthcare Conference May 17, 2021 Equillium Presents Multiple Posters at the 104th Annual Meeting of the American Association of Immunologists May 13, 2021 Equillium Reports First Quarter 2021 Financial Results and Provides Clinical Development Update May 13, 2021 Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association April 27, 2021 Equillium Announces Three Abstracts Accepted for Presentation at the 104th Annual Meeting of the American Association of Immunologists Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 21
June 11, 2021 Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
June 10, 2021 Equillium Presents Data on Target Engagement and Modulation of CD6 on T Cells with Itolizumab at the International Society for Advancement of Cytometry
June 7, 2021 Equillium to Collaborate with Oxford University and Kennedy Institute of Rheumatology to Investigate Role of the CD6-ALCAM Pathway and Itolizumab in Rheumatic Diseases
June 3, 2021 Equillium to Host Conference Call Following Presentation of Data from the EQUATE Study in Acute Graft Versus Host Disease at the EHA2021 Virtual Congress of the European Hematology Association on June 11
May 17, 2021 Equillium Presents Multiple Posters at the 104th Annual Meeting of the American Association of Immunologists
May 13, 2021 Equillium Reports First Quarter 2021 Financial Results and Provides Clinical Development Update
May 13, 2021 Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
April 27, 2021 Equillium Announces Three Abstracts Accepted for Presentation at the 104th Annual Meeting of the American Association of Immunologists
